Investors File Class Action Against Nano-X Imaging Over Production Claims

The complaint, filed in the United States District Court for the District of New Jersey, claims that Nano-X executives repeatedly overstated the success of their manufacturing scaling efforts. Investors allege the company obscured the fact that its production facilities were poorly aligned with market demand, leading to excessive cash burn and mounting operating expenses. According to the filing, these undisclosed issues necessitated significant restructuring and impairment charges that eventually triggered a sharp decline in share value.

The volatility surfaced on April 20, 2026, when Nano-X reported a $33.4 million net loss for the fourth quarter, driven largely by a $17.5 million impairment charge related to its Korean manufacturing facility. During an earnings call that day, CEO Erez Meltzer confirmed the company was abandoning its internal production model in favor of outsourced manufacturing to curb losses. Following these disclosures, the company’s stock price dropped 24.39%, closing at $2.155 per share.

Investors who acquired Nano-X securities during the specified period have until August 11, 2026, to petition the court for lead plaintiff status. Pomerantz LLP, the firm representing the class, is currently coordinating inquiries regarding the action.